Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (231-240 of 676) with videos related to

Pageof 68
Sort By:
Expert Opinion on Investigational Drugs|August 13, 2013
Perifosine--a new option in treatment of acute myeloid leukemia?Janusz Krawczyk, Niamh Keane, Ronan Swords, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 17, 2017
Black and minority ethnic group involvement in health and social care research: A systematic reviewShoba Dawson, Stephen M Campbell, Sally J Giles, et al.
Reproductive Biomedicine Online|January 23, 2024
Corrigendum to 'Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy' Reproductive Biomedicine Online. 2023 Aug;47(2):103222J Giles, M Cruz, A Cobo, et al.
Cancer|August 14, 2002
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group studyAnn F Mohrbacher, Stephanie A Gregory, Don A Gabriel, et al.
Leukemia & Lymphoma|May 9, 2001
Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemiaJ R Beck, J Guilhot, F J Giles, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Troxacitabine activity in extramedullary myeloid leukemiaYesid Alvarado, Hagop M Kantarjian, Jorge E Cortes, et al.
Leukemia|September 30, 2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsR-H Xu, H Pelicano, H Zhang, et al.
Clinical and Experimental Pharmacology & Physiology|September 28, 2006
A proteomic analysis of the acute effects of high-intensity exercise on skeletal muscle proteins in fasted ratsKym J Guelfi, Tammy M Casey, Jeffrey J Giles, et al.
Leukemia|December 1, 2006
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphomaT Haritunians, A Mori, J O'Kelly, et al.
Australasian Radiology|November 1, 1994
Colour duplex ultrasound: a screening modality for femoropopliteal disease in patients with intermittent claudicationR J Linke, R P Davies, A J Giles, et al.
Pageof 68

Showing results (231-240 of 676) with videos related to

Sort By:
Pageof 68
Expert Opinion on Investigational Drugs|August 13, 2013
Perifosine--a new option in treatment of acute myeloid leukemia?Janusz Krawczyk, Niamh Keane, Ronan Swords, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 17, 2017
Black and minority ethnic group involvement in health and social care research: A systematic reviewShoba Dawson, Stephen M Campbell, Sally J Giles, et al.
Reproductive Biomedicine Online|January 23, 2024
Corrigendum to 'Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy' Reproductive Biomedicine Online. 2023 Aug;47(2):103222J Giles, M Cruz, A Cobo, et al.
Cancer|August 14, 2002
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group studyAnn F Mohrbacher, Stephanie A Gregory, Don A Gabriel, et al.
Leukemia & Lymphoma|May 9, 2001
Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemiaJ R Beck, J Guilhot, F J Giles, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Troxacitabine activity in extramedullary myeloid leukemiaYesid Alvarado, Hagop M Kantarjian, Jorge E Cortes, et al.
Leukemia|September 30, 2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsR-H Xu, H Pelicano, H Zhang, et al.
Clinical and Experimental Pharmacology & Physiology|September 28, 2006
A proteomic analysis of the acute effects of high-intensity exercise on skeletal muscle proteins in fasted ratsKym J Guelfi, Tammy M Casey, Jeffrey J Giles, et al.
Leukemia|December 1, 2006
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphomaT Haritunians, A Mori, J O'Kelly, et al.
Australasian Radiology|November 1, 1994
Colour duplex ultrasound: a screening modality for femoropopliteal disease in patients with intermittent claudicationR J Linke, R P Davies, A J Giles, et al.
Pageof 68